Pinned
For most of modern medicine, the question has been: whatβs wrong with you?
We built Lucis to ask a different one: what if someone had looked earlier?
Today, we raised $20M Series A led by Singular, with General Catalyst and Y Combinator to serve Europe.
00:00



